Bayer AG (OTC Pink - Current Information:BAYRY)
| 14.47 Delayed Data As of Mar 31 |  -0.11 / -0.75%Today’s Change | 12.55 Today|||52-Week Range 21.59 | -28.65% Year-to-Date |
Latest BAYRY News | Press Releases
| Is Bayer Stock a Buy? Mar 25 / MotleyFool.com - Paid Partner Content | Teva Donating More Than 10 Million Doses of Hydroxychloroquine as Potential COVID-19 Treatment Mar 20 / MotleyFool.com - Paid Partner Content |
| All the Drugs Proving Anecdotally Effective Against COVID-19, and the Companies That Make Them Mar 21 / MotleyFool.com - Paid Partner Content | Mylan Ramps Up Production of Hydroxychloroquine as a Potential COVID-19 Treatment Mar 19 / MotleyFool.com - Paid Partner Content |
| Are Chloroquine and Hydrochloroquine Approved to Treat COVID-19? Mar 20 / MotleyFool.com - Paid Partner Content | Bayer Is Donating Its Malaria Drug That Could Help Coronavirus Patients In The U.S. Mar 18 / MotleyFool.com - Paid Partner Content |
Today’s Trading
| Previous close | 14.58 |
| Today’s open | 14.61 |
| Day’s range | 14.34 - 14.70 |
| Volume | 745,525 |
| Average volume (3 months) | 563,035 |
| Market cap | $55.2B |
Data as of 03/31/2020
Growth & Valuation
| Earnings growth (last year) | +31.63% |
| Earnings growth (this year) | +12.27% |
| Earnings growth (next 5 years) | +7.04% |
| Revenue growth (last year) | +4.36% |
| P/E ratio | -- |
| Price/Sales | 1.65 |
| Price/Book | 1.04 |
Competitors
| No competitors data available. |
Financials
| Next reporting date | April 27, 2020 |
| EPS forecast (this quarter) | $0.67 |
| Annual revenue (last year) | $48.7B |
| Annual profit (last year) | $2.7B |
| Net profit margin | 5.54% |
Profile
Sector Health Technology |
Industry Pharmaceuticals: Other |
No executives to display |
Corporate headquarters Leverkusen, Nordrhein-westfalen |
Forecasts
Chart unavailable
